Table 1.
Clinical characteristics of the study population
| Characteristic | Study Population n = 976 |
|---|---|
| ACS -- no. (%) | |
| STEMI | 711 (72.8) |
| NSTEMI | 266 (27.2) |
| Age at recruitment -- yr | 52 ± 8,7 |
| ≤ 55 | 601 (61.6) |
| Cardiovascular risk factor -- no. (%) | |
| Diabetes mellitus | 131 (13.4) |
| Hypertension | 507 (51.9) |
| Hyperlipidaemia | 529 (54.2) |
| Former or current smoker | 843 (86.4) |
| BMI -- kg/m2 | 28 ± 4.97 |
| BMI ≥ 30 kg/m2 | 280 (28.7) |
| Positive family history of MI -- no. (%) | 361 (37.0) |
| Event -- no. (%) | |
| Previous MI | |
| > 14 days | 99 (10.1) |
| < 14 days | 9 (0.9) |
| CAD | 156 (16.0) |
| PCI | 111 (11.4) |
| CABG | 27 (2.8) |
| Stroke | 14 (1.4) |
| PAOD | 26 (2.6) |
Data are shown as mean ± standard deviation; MI myocardial infarction, STEMI ST-elevation myocardial infarction, NSTEMI non ST-elevation myocardial infarction, CAD coronary artery disease, PCI percutaneous coronary intervention, BMI body mass index, CABG coronary artery bypass grafting, PAOD peripheral artery occlusive disease.